Moderna | MRNA - Selling And Administration Expenses

Stock Price
43.48
Daily Change
0.93 2.19%
Monthly
35.16%
Yearly
27.25%
Q1 Forecast
42.71

Moderna reported $268M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Acadia Pharmaceuticals USD 124.9M 1.24M Sep/2025
Agios Pharmaceuticals USD 41.27M 4.6M Sep/2025
Alnylam Pharmaceuticals USD 262.59M 60.72M Sep/2025
Amgen USD 1.7B 9M Sep/2025
Arrowhead Research USD 37.18M 6.23M Sep/2025
Biogen USD 545.2M 38.6M Sep/2025
BioMarin Pharmaceutical USD 223.42M 8.86M Sep/2025
Celltrion KRW 249.98B 16.36B Sep/2025
Cspc Pharmaceutical CNY 1.97B 404.66M Sep/2025
Dianthus Therapeutics USD 8.2M 669K Sep/2025
Divis Laboratories Ltd INR 3.4B 10M Jun/2025
Gilead Sciences USD 1.35B 6M Sep/2025
GlaxoSmithKline GBP 2.16B 19M Sep/2025
Incyte USD 329.08M 1.94M Sep/2025
Ionis Pharmaceuticals USD 86.56M 4.04M Sep/2025
Kangmei Pharma CNY 274.41M 15.05M Sep/2025
Knight Therapeutics CAD 25.48M 119K Sep/2024
Laboratorios Farma EUR 35.32M 2.75M Jun/2025
Malin Corporation EUR 1.1M 400K Dec/2024
Moderna USD 268M 38M Sep/2025
Organigram Holdings CAD 8.86M 499K Sep/2025
Pharma Mar EUR 13.7M 983K Sep/2025
Qiagen NV USD 143.11M 5.64M Sep/2025
Regeneron Pharmaceuticals USD 775M 117.2M Dec/2025
Sarepta Therapeutics USD 77.11M 7.22M Sep/2025
Sartorius EUR 218.7M 6.5M Sep/2025
Sino Biopharmaceutical CNY 7.54B 2.23B Jun/2025
Tilray USD 24.85M 1.7M Sep/2025
Ultragenyx Pharmaceutical USD 86.62M 26K Sep/2025
United Therapeutics USD 152M 60.5M Sep/2025
Vertex Pharmaceuticals USD 445.1M 20.5M Sep/2025
Zz Pientze Pharmaceu CNY 171.91M 343.2M Sep/2025